Proteomics reveals a global phenotypic shift of NK cells in HCV patients treated with direct‐acting antivirals
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Proteomics reveals a global phenotypic shift of NK cells in HCV patients treated with direct‐acting antivirals ; day:06 ; month:08 ; year:2023 ; extent:22
European journal of immunology ; (06.08.2023) (gesamt 22)
- Creator
-
Bi, Wenjie
Kraft, Anke
Engelskircher, Sophie
Mischke, Jasmin
Witte, Moana
Klawonn, Frank
van Ham, Marco
Cornberg, Markus
Wedemeyer, Heiner
Hengst, Julia
Jänsch, Lothar
- DOI
-
10.1002/eji.202250291
- URN
-
urn:nbn:de:101:1-2023080715033261345454
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bi, Wenjie
- Kraft, Anke
- Engelskircher, Sophie
- Mischke, Jasmin
- Witte, Moana
- Klawonn, Frank
- van Ham, Marco
- Cornberg, Markus
- Wedemeyer, Heiner
- Hengst, Julia
- Jänsch, Lothar
Other Objects (12)
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Direct-acting antivirals and visceral leishmaniasis: a case report
Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Simple Predictive Markers and Clinicopathological Features of Primary Liver Cancer following HCV Clearance with Direct-Acting Antivirals
Efficacy and safety of direct-acting antivirals for HCV in patients with extrahepatic malignancies: real-life experience
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Effect of sustained virological response after direct-acting antivirals on liver fibrosis in patients with chronic HCV infection
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Direct-acting antivirals and visceral leishmaniasis: a case report
Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Simple Predictive Markers and Clinicopathological Features of Primary Liver Cancer following HCV Clearance with Direct-Acting Antivirals
Efficacy and safety of direct-acting antivirals for HCV in patients with extrahepatic malignancies: real-life experience
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Effect of sustained virological response after direct-acting antivirals on liver fibrosis in patients with chronic HCV infection
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Direct-acting antivirals and visceral leishmaniasis: a case report
Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Simple Predictive Markers and Clinicopathological Features of Primary Liver Cancer following HCV Clearance with Direct-Acting Antivirals
Efficacy and safety of direct-acting antivirals for HCV in patients with extrahepatic malignancies: real-life experience
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway